INTERNATIONAL PATENT: BEIJING SOLOBIO GENETECHNOLOGY CO., LTD., 北京三诺佳邑生物技术有限责任公司 FILES APPLICATION FOR "MULTI-SPECIFIC ANTIBODY SPECIFICALLY BINDING TO HBV PRE-S1 ANTIGEN, PD-L1 ANTIGEN AND CD3 ANTIGEN AND USE THEREOF"

Posted On: 2025-08-17

GENEVA, Aug. 17 -- BEIJING SOLOBIO GENETECHNOLOGY CO., LTD. (Room 401, Building 5, NO.36, Jinghai Er Road, Beijing Economic-Technological Development AreaDaxing District, Beijing 100176), 北京三诺佳邑生物技术有限责任公司 (中国北京市大兴区经济技术开发区经海二路36号5幢401室) filed a patent application (PCT/CN2025/073892) for "MULTI-SPECIFIC ANTIBODY SPECIFICALLY BINDING TO HBV PRE-S1 ANTIGEN, PD-L1 ANTIGEN AND CD3 ANTIGEN AND USE THEREOF" on Jan 22, 2025. With publication no. WO/2025/167631, the details related to the ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: BEIJING SOLOBIO GENETECHNOLOGY CO., LTD., 北京三诺佳邑生物技术有限责任公司 FILES APPLICATION FOR "MULTI-SPECIFIC ANTIBODY SPECIFICALLY BINDING TO HBV PRE-S1 ANTIGEN, PD-L1 ANTIGEN AND CD3 ANTIGEN AND USE THEREOF"